InvestorsHub Logo
Followers 52
Posts 9070
Boards Moderated 1
Alias Born 10/25/2007

Re: spartex post# 13215

Friday, 02/09/2024 9:55:59 AM

Friday, February 09, 2024 9:55:59 AM

Post# of 13431
news imminent -$$$$$

On 13-16 February, 2024

https://resvinet.org/conferences/rsvvw24/

Statement on RSVVW Abstract on mRNA-1345


At an upcoming presentation at the RSVVW’24 conference, Moderna will share follow-up data from its ongoing ConquerRSV Phase 3 study of its investigational RSV vaccine candidate, mRNA-1345.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News